Sacral Nerve Stimulation Market Growth Accelerated by Rising Prevalence of Overactive Bladder Disorder
Sacral Nerve Stimulation Market
Sacral
nerve stimulation is a treatment option for overactive bladder disorders that
involves implanting a small medical device called a neurostimulator to
stimulate the sacral nerves and restore control of the bladder. The devices
help improve symptoms like urgent need to urinate, frequency, and urge
incontinence associated with overactive bladder. Rising prevalence of
overactive bladder disorders driven by factors like aging population, obesity,
and diabetes is increasing the need for minimally invasive treatment options
like sacral nerve stimulation. The global Sacral Nerve Stimulation Market is
estimated to be valued at US$ 444.7 Mn in 2023 and is expected to exhibit a
CAGR of 5.2% over the forecast period 2024 to 2031, as highlighted in a new
report published by Coherent Market Insights.
Market key trends:
The key trend fueling growth in the global sacral nerve stimulation market is
rising adoption of minimally invasive procedures over conventional bladder
surgery. Sacral nerve stimulation offers notable advantages like faster
recovery, lower morbidity risk, and better results compared to surgical
alternatives. Technological advancements are also playing a role with companies
introducing recharge-free and magnet-less neurostimulators to overcome past
device limitations and improve patient comfort and compliance. Expanding
applications of sacral nerve stimulation beyond overactive bladder into new
areas like fecal incontinence and chronic pelvic pain will further expand the
market opportunity over the forecast period.
Segment
Analysis
The global sacral nerve stimulation market is dominated by the implantable
sacral nerve stimulators sub segment. This is because implantable devices offer
long term relief from urinary and fecal incontinence as compared to external
devices which need to be connected through wires. Implantable devices also have
better patient compliance and acceptance.
Key Takeaways
The Global
Sacral Nerve Stimulation Market Demand is expected to witness high
growth over the forecast period owing to rising geriatric population suffering
from urinary incontinence and fecal incontinence.
Regional analysis: North America currently dominates the global sacral nerve
stimulation market due to growing awareness about new treatment options for
urinary incontinence and favorable reimbursement policies. However, Asia Pacific
is expected to grow at the fastest pace during the forecast period due to
rising medical tourism, growing healthcare investments and increasing focus of
key players in countries like China and India.
Key
players operating in the global sacral nerve stimulation market are Medtronic
plc, Boston Scientific Corporation, Nevro Corp, StimWave Technologies Inc.,
Axonics, Inc. and Synapse Biomedical. Medtronic plc currently leads the global
market owing to its wide product portfolio and robust geographic presence
across the globe.
For more details on the report, Read- https://www.trendingwebwire.com/sacral-nerve-stimulation-market-growth-demand-and-overview/
Get more insights on this
topic: https://coolbio.org/pharmacogenomics-a-promising-new-approach-to-personalized-medicine/
Comments
Post a Comment